Application of Artificial Intelligence to Structural-Functional Biology and Drug Design

webinar

Thu, 21 Oct 2021, 16:00 CEST (Berlin)

Dr. Irina Moreira, University of Coimbra, Portugal

Application of Artificial Intelligence to Structural-Functional Biology and Drug Design

Despite technological advances, the conventional process of drug discovery and development still shows limited therapeutic efficacy. To date, we only partially understand disease pathophysiology, we see an overall deficiency in developing therapeutics that target overlapping dysregulated pathways, and the choice of therapeutically irrelevant drug targets.
A key difficulty lies in mining and interpretation of an ever-growing and overwhelming wealth of diverse data — data, that is disparate from global, systemic approaches with an increased granularity of evidence. A subsequent challenge is to determine the relative importance of different pieces of evidence when combining all the available information to suggest promising, sensible targets for drug discovery. Given the latest advances in AI, this enormous task can now be pursued.

Join this webinar to hear and see Irina giving some examples on such target characterization.

Current news

category
Software
Double Release — SeeSAR 11.1 and infiniSee 3.2
October 14, 2021 12:19
The BioSolveIT October updates are here and this time we are proud to announce a simultanious double release of both our platforms SeeSAR and infiniSee. SeeSAR 11.1 SeeSAR Hephaestus received a powerful update to support users in their drug discovery efforts. The covalent complex assessment received a visual update where...
Read on
category
Software
Asinex Covalent Library with over 50k molecules now available for SeeSAR
September 20, 2021 19:21
Today’s update for the drug design dashboard SeeSAR features the ready-to-dock covalent library set by Asinex including over 50k possible drug candidates. Warheads of compounds have been translated into a ready-to-dock format for SeeSAR for convenient import and easy covalent docking access. The broad range of featured warheads allows you...
Read on
category
Challenge
Winner of Scientific Challenge Fall 2020: FtsZ Inhibitors
September 20, 2021 17:16
We congratulate Benjamin Strickland from the Drew University to winning the Scientific Challenge Fall 2020! In his project he aims to discover novel antibacterial scaffolds and leads for the bacterial cellular division protein filamenting temperature-sensitive mutant Z (FtsZ). The synergistic combination of SeeSAR and infiniSee during his evolutionary virtual high throughput screening...
Read on